跳至主要内容
临床试验/NCT01773083
NCT01773083终止3 期

Randomized Controlled Trial Investigating the Efficacy and Safety of Nebulized Heparin Versus Placebo in Burn Patients With Inhalation Trauma (Hepburn)

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)8 个研究点 分布在 3 个国家目标入组 13 人开始时间: 2013年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
终止
入组人数
13
试验地点
8
主要终点
Number of ventilator-free days at day 28

研究概览

简要总结

The purpose of this international multi-center double-blind randomized placebo-controlled trial is to determine the effect of nebulized heparin, compared to placebo, on the number of ventilator-free days at day 28, in burn patients with confirmed inhalation trauma requiring mechanical ventilation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Informed consent
  • Age > 18 years
  • Need for invasive mechanical ventilation
  • Confirmed inhalation trauma (bronchoscopically)

排除标准

  • > 36 hours after trauma
  • Receiving invasive ventilation > 24 hours
  • Expected duration of mechanical ventilation < 24 hours
  • Chronic obstructive pulmonary disease GOLD stage III and IV
  • Any history of pulmonary hemorrhage in the past 3 months
  • Any history of significant bleeding disorder
  • Known allergy to heparin, including heparin-induced thrombocytopenia
  • Pregnancy or breast feeding
  • Unlikely to survive for > 72 hours
  • Total body surface area (TBSA) > 60%
  • Witnessed or proven aspiration (i.e., confirmed by bronchoscopy)

研究组 & 干预措施

unfractionated heparin

Experimental

25.000 IU/5 ml, will be nebulized 4 hourly (i.e. 6 times daily)

干预措施: unfractionated heparin (Drug)

placebo

Placebo Comparator

Sterile sodium chloride (NaCl 0.9%, Pfizer), in 5 ml, will be nebulized every 4 hours (i.e. 6 times daily)

干预措施: placebo (Drug)

结局指标

主要结局

Number of ventilator-free days at day 28

时间窗: at day 28

The number of ventilator-free days is defined as the number of days a patient is breathing without assist of a ventilator during the first 28 days; thus, the patient must be free of mechanical ventilation for 24 hours to have one ventilator-free day; if after successful detubation the patient requires a reintubation due to a surgical procedure, this reintubation will not count as a ventilator day - however, the day(s) will be counted as ventilator day(s) if mechanical ventilation is prolonged after surgery due to respiratory insufficiency.

次要结局

  • Clinical outcome parameters(daily or at day 28 and day 90)
  • Laboratory outcome parameters(Blood and lavage samples: on admission day and every other day for a maximum period of 14 days)
  • Safety parameters(daily, for a maximum period of 28 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Prof. Dr. Marcus J. Schultz

Prof. Dr.

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

研究点 (8)

Loading locations...

相似试验